Xtant Medical Holdings, Inc.XTNTNYSE
Loading
EBITDA Over TimeExpanding
Percentile Rank100
5Y CAGR+52.3%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

5Y CAGR
+52.3%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
8.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$10.90M+238.3%
2024$-7.88M-255.2%
2023$5.08M+193.5%
2022$-5.43M-116.0%
2021$-2.51M-289.2%
2020$1.33M+56.2%
2019$850000.00+101.6%
2018$-54.22M-85.0%
2017$-29.31M-47814.0%
2016$61434.00-